Spots Global Cancer Trial Database for A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN
Official Title: A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Study ID: NCT04949503
Interventions
Study Description
Brief Summary: This study is a retrospective real-world study. In this study, we plan to collect the clinical data of LASCCHN patients who received chemoradiotherapy combined with or without nimotuzumab .
Detailed Description: This study is a retrospective real-world study. The diagnosis and treatment of patients, disease management, and information collection are completely dependent on the daily medical practice. In this study, we plan to select 5 to 8 hospitals nationwide to collect the clinical data of LASCCHN patients who received chemoradiotherapy combined with or without nimotuzumab from January 2015 to December 2018. Patients included in the study will be followed up for survival. The main endpoint is 3-year overall survival (OS) rate; the secondary endpoint are 3-year progression-free survival (PFS) rate, 3-year Local-regional control (LRC) rate, objective response rate (ORR), disease control rate (DCR) and safety.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Cancer Hospital, Beijing, Beijing, China
The General Hospital of the People's Liberation Army, Beijing, Beijing, China
Sun Yat-sen University Cancer Centre, Guangzhou, Guangdong, China
First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Shannxi, China
Tianjin Cancer Hospital, Tianjin, Tianjin, China
Contact Details
Name: Jinyi Lang
Affiliation: Sichuan Cancer Hospital and Research Institute
Role: STUDY_CHAIR
Name: Chenping Zhang
Affiliation: Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medcine
Role: STUDY_CHAIR
Name: Junlin Yi
Affiliation: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
